Skip to content

Ginger trials report changes in inflammation markers

A review found shifts in laboratory markers, but these results do not establish symptom relief or prevention of disease.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

Across randomized trials, ginger supplementation was associated with shifts in inflammatory and antioxidant markers, including lower C-reactive protein. These are laboratory outcomes: the abstract does not report whether people felt better or developed fewer health problems. The authors highlight substantial differences between studies, so the pooled results need cautious interpretation.

Keep in mind

High heterogeneity limits interpretation. The abstract provides no detailed participant breakdown, trial durations or comparator descriptions, and it does not report clinical outcomes.

THE NUMBERS, WITH CONTEXT

What researchers found

-0.86 mg/L (95% CI -1.10 to -0.62)

C-reactive protein: weighted mean difference

With ginger supplementation; comparator conditions and measurement timeframes were not reported in the abstract.

Inflammopharmacology, 2025 · Original source ↓

What was measured

The review assessed markers of inflammation and antioxidant activity. Several markers shifted in directions the authors considered favorable, but the abstract reports laboratory results without showing whether those changes translated into health improvements.

Dose questions remain

The authors report a nonlinear dose-and-duration relationship for an inflammatory marker. The abstract does not provide the dose-specific estimates needed to evaluate a preferred supplement schedule or its applicability to individuals.

CHECK THE ORIGINAL

The original publication

Antioxidant and anti-inflammatory effects of ginger supplementation in adults: a GRADE-assessed systematic review and dose-response meta-analysis of randomised controlled trials.

Rjabi S, Barbarz H, Makhtoomi M et al.
Inflammopharmacology · 2025

PubMed ID
41123858
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.